
Myomo (MYO) Stock Forecast & Price Target
Myomo (MYO) Analyst Ratings
Bulls say
Myomo is a medical robotics company that has seen significant growth, particularly in its orthopaedic niche market due to a positive Medicare ruling. This ruling has greatly expanded the company's potential market, making it an attractive investment with solid sales, backlog, and revenue growth projections for 2026. Additionally, Myomo's continued momentum and commercialization efforts in the U.S. and international markets bode well for future success and potential upside opportunities.
Bears say
Myomo is a wearable medical robotics company that has experienced solid sales and backlog growth, and has a positive outlook due to a recent positive Medicare ruling that greatly expands their potential market. Their raised guidance for 2026 revenue and partnerships with O&P providers through insurance reimbursement add to their strong financial prospects.
This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.
Myomo (MYO) Analyst Forecast & Price Prediction
Start investing in Myomo (MYO)
Order type
Buy in
Order amount
Est. shares
0 shares